Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	94
Overall Study	STARTED	ACZ885	95
Overall Study	Safety Analysis Set	Placebo	94
Overall Study	Safety Analysis Set	ACZ885	95
Overall Study	Pharmacokinetic (PK) Analysis Set	Placebo	0
Overall Study	Pharmacokinetic (PK) Analysis Set	ACZ885	95
Overall Study	Pharmacodynamic (PD) Analysis Set	Placebo	92
Overall Study	Pharmacodynamic (PD) Analysis Set	ACZ885	92
Overall Study	Imaging Analysis Set	Placebo	92
Overall Study	Imaging Analysis Set	ACZ885	92
Overall Study	COMPLETED	Placebo	73
Overall Study	COMPLETED	ACZ885	67
Overall Study	NOT COMPLETED	Placebo	21
Overall Study	NOT COMPLETED	ACZ885	28

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00995930/flow